Effect and safety of anaprazole in the treatment of duodenal ulcers: a randomized, rabeprazole-controlled, phase III non-inferiority study
CONCLUSIONS: The efficacy of anaprazole is non-inferior to that of rabeprazole in Chinese patients with duodenal ulcers.REGISTRATION: ClinicalTrials.gov, NCT04215653.PMID:36580650 | DOI:10.1097/CM9.0000000000002508
Source: Chinese Medical Journal - Category: General Medicine Authors: Huiyun Zhu Xue Pan Li Zhang Hongxin Sun Huizhen Fan Zhongwei Pan Caibin Huang Zhenwang Shi Jin Ding Qi Wang Yiqi Du Nonghua Lyu Zhaoshen Li Source Type: research
More News: China Health | Duodenal Ulcer | General Medicine | Genetics | Helicobacter Pylori | Peptic Ulcer | Proton Pump Inhibitors PPIs | Study